🟢 Aspire BioPharma is trading 8.27% up today as Fed decision eases policy uncertainty

Aspire BioPharma is trading 8.27% up now at $9.16 as U.S. markets rally following the Federal Reserve’s September 16, 2026 rate decision and easing policy uncertainty.

• The S&P 500, Nasdaq Composite, and Dow are up 0.96%, 1.24%, and 0.53%, respectively.
• No new company-specific September 17 catalyst was identified; the latest major announcement was the September 9 $10 million repurchase authorization.